Skip to main content
. 2009 May 27;10:44. doi: 10.1186/1471-2350-10-44

Table 1.

Description of the MORGAM cohorts

Number of individuals

Cohort Subcohorta Incident cases outside subcohort All Non-cases CHDb Strokeb Smokersc Males Age at baselined (years) Follow-up median/max (years)
FINRISK
(Finland)
700
(609/91)
476 1176 609
(51.8%)
382 (32.5%) 185 (15.7%) 285 (24.2%) 827 (70.3%) 57.0 [25–74] 8.07/10.96
ATBC
(Finland)
849 (718/131) 421 1270 718 (56.5%) 343 (27.0%) 209 (16.5%) 1007 (79.3%) 1270 (100%) 63.4 [54–76] 7.12/8.29
Sweden 136 (128/8) 59 195 128 (65.6%) 29 (14.9%) 38 (19.5%) 37 (19.0%) 121 (62.0%) 55.8 [24–73] 6.04/10.87
PRIME
N.Ireland
143 (135/8) 108 251 135 (53.8%) 103 (41.0%) 13 (5.2%) 66 (26.3%) 251 (100%) 54.9 [50–60] 5.14/5.99
PRIME
France
188 (182/6) 108 296 182 (61.5%) 98 (33.1%) 16 (5.4%) 73 (24.7%) 296 (100%) 55.3 [49–60] 5.28/7.61
Entire 2016 (1772/244) 1172 3188 1772 (55.6%) 955 (30.0%) 461 (14.5%) 1468 (46.0%) 2765 (86.7%) 59.2 [24–76] 6.33/10.96

a Total number of individuals in the random subcohort (non-cases/cases)

b In presence of several events, only the first event was considered.

c Daily cigarette smoker at baseline

d Mean age [min - max]